# FDA Inspection 1123741 - Bristol Myers Squibb - April 22, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb/ddbb9a9b-d0d9-448a-b3ed-40a7da97ae20
Source feed: FDA_Inspections

> FDA Inspection 1123741 for Bristol Myers Squibb on April 22, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123741
- Company Name: Bristol Myers Squibb
- Inspection Date: 2020-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1165884 - 2022-02-02](https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb/9ed1c56a-ffa5-47d8-b8ee-fb8e2ecc2089)
- [FDA Inspection 1144339 - 2021-05-24](https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb/f31c1669-da4a-4e0a-88d5-f2bc632af517)
- [FDA Inspection 900475 - 2014-10-16](https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb/68452fe3-43b6-4661-9ef2-8447acfbb3fb)
- [FDA Inspection 779511 - 2012-04-05](https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb/9c89c7a0-9c65-4d74-8b0e-2a755612e953)
- [FDA Inspection 766881 - 2012-01-27](https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb/0611e04c-4d85-49ab-af00-b7f7ad259ec1)

Company: https://www.globalkeysolutions.net/companies/bristol-myers-squibb/6be6b425-4587-4e43-9934-b3cda7b6457c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c